bluebird bio Inc (NAS:BLUE)
$ 0.4171 0.0121 (2.99%) Market Cap: 81.10 Mil Enterprise Value: 376.50 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 31/100

bluebird bio Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2023 / 03:30PM GMT
Release Date Price: $8.22 (+2.62%)
Matthew Bannon

Okay. Welcome to the 41st Annual JPMorgan Healthcare Conference. My name is Matt Bannon, and I'm a health care banker here at JPM. I'm really excited to be setting the stage for our next presenting company, bluebird bio. And presenting on behalf of bluebird, we have CEO, Andrew Obenshain. Andrew, Stage is yours.

Andrew Obenshain
bluebird bio, Inc. - President, CEO & Director

Good morning, everyone, to everyone here in the room and for later on the webcast. My name is Andrew Obenshain. I'm the CEO of bluebird bio. And thanks, Matt, and thanks, JPMorgan, for the opportunity to share the bluebird story as we kick off 2023, and which is poised to be a really significant year from both a regulatory and a commercial perspective for bluebird bio.

In today's presentation and in the Q&A, we will be making forward-looking statements. I will refer you to our filings with the SEC to this statement, which is in this presentation, which is on our website.

Many of you are familiar with the bluebird story. And the last time we stood on the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot